CERO THERAPEUTICS HOLDINGS, INC. Proceeds from Related Party Debt
CERO THERAPEUTICS HOLDINGS, INC. (CERO) reported Proceeds from Related Party Debt of $905.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-02.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRelatedPartyDebt · last filed 2024-04-02
- CERO THERAPEUTICS HOLDINGS, INC. proceeds from related party debt for the quarter ending 2023-12-31 was $160.00K.
- CERO THERAPEUTICS HOLDINGS, INC. proceeds from related party debt for the quarter ending 2023-09-30 was $220.00K.
- CERO THERAPEUTICS HOLDINGS, INC. proceeds from related party debt for fiscal 2023 was $905.00K, a 39.23% increase from fiscal 2022.
- CERO THERAPEUTICS HOLDINGS, INC. proceeds from related party debt for fiscal 2022 was $650.00K.
| Period end | Proceeds from Related Party Debt 3 month | Proceeds from Related Party Debt 6 month | Proceeds from Related Party Debt 7 month | Proceeds from Related Party Debt 9 month | Proceeds from Related Party Debt 12 month |
|---|---|---|---|---|---|
| 2023-12-31 | $160.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-02 | $380.00K derived: sum of 2 quarters · filed 2024-04-02 | $905.00K 10-K · filed 2024-04-02 | ||
| 2023-09-30 | $220.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $745.00K 10-Q · filed 2023-11-09 | |||
| 2023-06-30 | $525.00K 10-Q · filed 2023-08-14 | ||||
| 2022-12-31 | $650.00K 10-K · filed 2024-04-02 | ||||
| 2021-12-31 | $55.00K 10-K · filed 2023-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |